Dr Matiss Ozols

Principal Bioinformatician

 
Dedicated to pioneering computational methods, I analyze diverse datasets, including scRNA and proteomic. With a commitment to cellular insights, I emphasize collaboration to democratize genomics access. My work reflects the shared mission of advancing global scientific discovery and maximizing the utility of complex data.

Matiss has always been at the intersection of cutting-edge biological research and advanced computational methodologies. Rooted in his early passion for understanding the intricacies of life, he has diligently honed his skills in pipeline development, statistical inference, and both traditional and deep machine learning techniques. This technical prowess is complemented by his full-stack web development capabilities, enabling him to create tools that not only analyze but also disseminate multi-omics data effectively.

His research gravitates towards the exploration of human genetics and proteomics, where he seeks answers to pressing questions related to genetic-associated diseases. The cardiovascular and dermatological fields have been particular areas of emphasis, driven by their profound impact on global health.

A significant aspect of Matiss’s work also delves into the rapidly evolving field of single-cell RNA (scRNA) analysis. Recognizing the transformative potential of this technology in unraveling cellular heterogeneity and understanding disease mechanisms at an unprecedented resolution, he is keen on leveraging its power to uncover new insights, especially in the context of genetic-associated diseases.

During his Ph.D., Matiss ventured into the realm of biomarker discovery and validation. It was here that he melded deep learning techniques with proteomic studies, leading to the prediction and validation of novel bioactives.

Looking forward, Matiss is driven by the vision of fostering collaborative environments that harness the power of multi-omics data. His overarching goal is to pave the way for data-driven biological discoveries that are not only frequent but also universally accessible, ensuring that the ensuing innovations benefit humanity at large.

My timeline